Li-hsin Cheng

1 University Road
Tainan, TNQ 70101, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

P-glycoprotein 1 as a shared target for resensitizing drug-resistant tumor cells and preventing fibronectin-driven metastasis.

P-glycoprotein 1 as a shared target for resensitizing drug-resistant tumor cells and preventing fibronectin-driven metastasis.

Journal: Theranostics

Published: January 13, 2026

Quinoline-5,8-dione CDC25 inhibitors: Potent anti-cancer agents in leukemia and patient-derived colorectal organoids.

Quinoline-5,8-dione CDC25 inhibitors: Potent anti-cancer agents in leukemia and patient-derived colorectal organoids.

Journal: European journal of medicinal chemistry

Published: July 12, 2025

The hidden hazard in kitchen environment: A preliminary study of health risks associated with inhaling acrylamide during French fries frying.

The hidden hazard in kitchen environment: A preliminary study of health risks associated with inhaling acrylamide during French fries frying.

Journal: Ecotoxicology and environmental safety

Published: June 11, 2025

Chemotherapy resistance of urinary bladder cancer mediated by a Notch and Wnt co-regulatory module of stemness.

Chemotherapy resistance of urinary bladder cancer mediated by a Notch and Wnt co-regulatory module of stemness.

Journal: Stem cells (Dayton, Ohio)

Published: June 09, 2025

Emerging Roles of ACTL6A as an Oncogenic Hub: Transcriptional Regulation and Beyond.

Emerging Roles of ACTL6A as an Oncogenic Hub: Transcriptional Regulation and Beyond.

Journal: Molecular cancer research : MCR

Published: January 16, 2025

OCT4-mediated upregulation of DUSP6 promotes metastasis in non-small-cell lung cancer.

OCT4-mediated upregulation of DUSP6 promotes metastasis in non-small-cell lung cancer.

Journal: Journal of Cancer

Published: December 12, 2024

Multi-omics profiling reveals PLEKHA6 as a modulator of β-catenin signaling and therapeutic vulnerability in lung adenocarcinoma.

Multi-omics profiling reveals PLEKHA6 as a modulator of β-catenin signaling and therapeutic vulnerability in lung adenocarcinoma.

Journal: American journal of cancer research

Published: December 09, 2024

Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids.

Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids.

Journal: Journal of medicinal chemistry

Published: September 25, 2024

OCT4 promotes lung cancer progression through upregulation of VEGF-correlated chemokine-1.

OCT4 promotes lung cancer progression through upregulation of VEGF-correlated chemokine-1.

Journal: International journal of medical sciences

Published: August 18, 2024

Aberrant expression of nuclear prothymosin α contributes to epithelial-mesenchymal transition in lung cancer.

Aberrant expression of nuclear prothymosin α contributes to epithelial-mesenchymal transition in lung cancer.

Journal: Molecular oncology

Published: June 13, 2024

HSP90/LSD1 dual inhibitors against prostate cancer as well as patient-derived colorectal organoids.

HSP90/LSD1 dual inhibitors against prostate cancer as well as patient-derived colorectal organoids.

Journal: European journal of medicinal chemistry

Published: May 23, 2024

ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells.

ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells.

Journal: Molecular oncology

Published: April 01, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026